BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China
· Delayed Price · Currency is CNY 53.00
+0.08 (0.15%)
At close: Jun 27, 2025, 2:57 PM CST
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 22.39 billion as of June 27, 2025. Its market cap has increased by 46.39% in one year.
Market Cap
22.39B
Enterprise Value
23.92B
Revenue
1.19B
Ranking
n/a
PE Ratio
161.85
Stock Price
53.00
Market Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 22.39B, an increase of 78.38%. That is a compound annual growth rate of 10.81%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 351.36B |
| Shenzhen Mindray Bio-Medical Electronics | 277.01B |
| WuXi AppTec | 195.03B |
| Zhangzhou Pientzehuang Pharmaceutical., | 120.94B |
| Sichuan Biokin Pharmaceutical | 119.86B |
| Aier Eye Hospital Group | 115.64B |
| Shanghai United Imaging Healthcare | 104.54B |
| Yunnan Baiyao Group Co.,Ltd | 98.85B |